These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
742 related articles for article (PubMed ID: 11834588)
1. Brain function in Duchenne muscular dystrophy. Anderson JL; Head SI; Rae C; Morley JW Brain; 2002 Jan; 125(Pt 1):4-13. PubMed ID: 11834588 [TBL] [Abstract][Full Text] [Related]
2. Reduced postsynaptic GABAA receptor number and enhanced gaboxadol induced change in holding currents in Purkinje cells of the dystrophin-deficient mdx mouse. Kueh SL; Dempster J; Head SI; Morley JW Neurobiol Dis; 2011 Sep; 43(3):558-64. PubMed ID: 21601636 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms and Consequences of Cerebellar Purkinje Cell Disinhibition in a Mouse Model of Duchenne Muscular Dystrophy. Wu WC; Bradley SP; Christie JM; Pugh JR J Neurosci; 2022 Mar; 42(10):2103-2115. PubMed ID: 35064002 [TBL] [Abstract][Full Text] [Related]
4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy. Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351 [TBL] [Abstract][Full Text] [Related]
5. Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy. Chesshyre M; Ridout D; Hashimoto Y; Ookubo Y; Torelli S; Maresh K; Ricotti V; Abbott L; Gupta VA; Main M; Ferrari G; Kowala A; Lin YY; Tedesco FS; Scoto M; Baranello G; Manzur A; Aoki Y; Muntoni F J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1360-1372. PubMed ID: 35083887 [TBL] [Abstract][Full Text] [Related]
6. Cognitive dysfunction in the dystrophin-deficient mouse model of Duchenne muscular dystrophy: A reappraisal from sensory to executive processes. Chaussenot R; Edeline JM; Le Bec B; El Massioui N; Laroche S; Vaillend C Neurobiol Learn Mem; 2015 Oct; 124():111-22. PubMed ID: 26190833 [TBL] [Abstract][Full Text] [Related]
7. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy. Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083 [TBL] [Abstract][Full Text] [Related]
8. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models. van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492 [TBL] [Abstract][Full Text] [Related]
10. Startle responses in Duchenne muscular dystrophy: a novel biomarker of brain dystrophin deficiency. Maresh K; Papageorgiou A; Ridout D; Harrison NA; Mandy W; Skuse D; Muntoni F Brain; 2023 Jan; 146(1):252-265. PubMed ID: 35136951 [TBL] [Abstract][Full Text] [Related]
11. GABA(A) receptor expression and inhibitory post-synaptic currents in cerebellar Purkinje cells in dystrophin-deficient mdx mice. Kueh SL; Head SI; Morley JW Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):207-10. PubMed ID: 17941889 [TBL] [Abstract][Full Text] [Related]
12. Impaired long-term spatial and recognition memory and enhanced CA1 hippocampal LTP in the dystrophin-deficient Dmd(mdx) mouse. Vaillend C; Billard JM; Laroche S Neurobiol Dis; 2004 Oct; 17(1):10-20. PubMed ID: 15350961 [TBL] [Abstract][Full Text] [Related]
13. Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy. Ponnusamy S; Sullivan RD; You D; Zafar N; He Yang C; Thiyagarajan T; Johnson DL; Barrett ML; Koehler NJ; Star M; Stephenson EJ; Bridges D; Cormier SA; Pfeffer LM; Narayanan R Hum Mol Genet; 2017 Jul; 26(13):2526-2540. PubMed ID: 28453658 [TBL] [Abstract][Full Text] [Related]
14. Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice. Vaillend C; Chaussenot R Hum Mol Genet; 2017 Mar; 26(6):1041-1055. PubMed ID: 28087735 [TBL] [Abstract][Full Text] [Related]
15. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy. Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419 [TBL] [Abstract][Full Text] [Related]
16. Why is early-onset atrial fibrillation uncommon in patients with Duchenne muscular dystrophy? Insights from the mdx mouse. Nguyen MN; Hooper C; Stefanini M; Vrellaku B; Carnicer R; Wood MJ; Simon JN; Casadei B Cardiovasc Res; 2024 Apr; 120(5):519-530. PubMed ID: 38270932 [TBL] [Abstract][Full Text] [Related]
17. Stay TL; Miterko LN; Arancillo M; Lin T; Sillitoe RV Dis Model Mech; 2019 Dec; 13(2):. PubMed ID: 31704708 [TBL] [Abstract][Full Text] [Related]
18. The role of dystrophin in the central nervous system: a mini review. Sekiguchi M Acta Myol; 2005 Oct; 24(2):93-7. PubMed ID: 16550924 [TBL] [Abstract][Full Text] [Related]
19. Abnormalities in brain structure and biochemistry associated with mdx mice measured by in vivo MRI and high resolution localized (1)H MRS. Xu S; Shi D; Pratt SJP; Zhu W; Marshall A; Lovering RM Neuromuscul Disord; 2015 Oct; 25(10):764-72. PubMed ID: 26236031 [TBL] [Abstract][Full Text] [Related]
20. The neurobiology of duchenne muscular dystrophy: learning lessons from muscle? Blake DJ; Kröger S Trends Neurosci; 2000 Mar; 23(3):92-9. PubMed ID: 10675908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]